* Creative Medical Technology Holdings Inc CELZ.OQ
CELZ.O is
expected to show a rise in quarterly revenue when it reports
results on August 14 (estimated).
* The Phoenix Arizona-based company is expected to report
revenue
of $15 thousand, according to the estimate from one analyst,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Creative Medical
Technology Holdings Inc is for a loss of 83 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Creative
Medical
Technology Holdings Inc is $30, above its last closing price
of $5.17.
This summary was machine generated August 12 at 02:03 GMT. All
figures in US dollars unless otherwise stated